Syqe Enters Into Distribution Agreement With TerrAscend to Bring Revolutionary Medical Cannabis Treatment to Canada Leading pharma-tech company inks deal with TerrAscend to bring the first and only inhalation...
Syqe Medical Receives Regulatory Approval to Release World’s First Drug Delivery Device for Precise Dosing of Cannabis Leading pharma-tech company launches its first-in-class, pharmaceutical-grade cannabis inhaler in Israel; enabling...
The Canadian Cannabis Industry: Enter the Giants Guest Post by Michael Black, Director Consulting & Deals at PwC Canada The entrance of Constellation Brands in the cannabis industry has...
Israeli cannabis device maker Syqe Medical, which includes Philip Morris International as a major investor, has signed Teva Pharmaceuticals (NYSE: TEVA) to distribute its inhaler following its approval by...
An unconfirmed Reuters report suggests that tobacco giant Philip Morris is investing $20mm into Israeli company Syqe Medical to develop a device aimed at reducing health risks associated with...
The Syqe Inhaler™ – A first-in-class pocket-sized metered-dose cannabis inhaler Known for its dynamic tech startups, agricultural innovations, and security solutions, Israel could soon add cannabis powerhouse to the list, thanks to...
